Epicriptine

This classification denotes an alpha-adrenergic blocking agent with the molecular formula C32H43N5O5, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 5M64643B5U, chemically known as 9,10alpha-dihydro-13-epi-beta-ergocryptine but generally known as epicriptine, which bears US NIH Compound Identifier 65667. European Medicines Agency schedules Epicriptine in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB06564MIG. The term EPICRIPTINE is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 3, No. 3, 1989, List 29). EPICRIPTINE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule epicriptine under HS 29396900 and SITC 54146. As of Q4 2014, EPICRIPTINE remains the US FDA Preferred Term for this commodity. Epicriptine bears US NLM identifiers UMLS ID C0304433 and NCI Concept Code C75934. SMILES: O1C2(O)N(C(C(=O)N3C2CCC3)C(CC)C)C(=O)C1(NC(=O)C1CC2C(N(C1)C)CC1C3C2CCCC3[NH]C1)C(C)C.